New Release: Alpha testing version has been released.
Tenoxicam
M01A - NSAIDs and antirheumatic products, non-steroidsATC M01AC02Small moleculeNatural product
JFDA label: Tenox capsule
Indications
Approved
Rheumatic Diseases — rheumatic disease
Off-label
Pain
Class profile
cox1_IC50_uM
7.6
cox2_IC50_uM
11.0
cox2_selectivity
0.6909090909090909
inhibitionType
reversible
preferentialCOX2
0
selectiveCOX2
0
plateletEffect
1
source
Warner1999/Vane1996/ChEMBL
Pregnancy & Lactation
Pregnancy
Monitoring
Efficacy
Pain and inflammation control (VAS/NRS scores, joint mobility, functional status); minimum effective dose
Toxicity
Blood pressure (raises BP, antagonises antihypertensives); renal function (SCr, eGFR — especially in elderly, heart failure, CKD, dehydrated); Hb/faecal occult blood (GI bleeding); LFTs; oedema
Clinical pearl
Use the lowest effective dose for the shortest duration. Consider co-prescribing a proton pump inhibitor if GI risk factors present. COX-2 selective agents reduce GI but not CV risk.
Counseling
Take with food or milk to reduce GI upset. Report black stools, blood in urine, or significant ankle swelling. Monitor blood pressure regularly if hypertensive.